Apolipoprotein E

Apolipoprotein E

Apolipoprotein E (APOE) is an apoprotein found in the chylomicron that binds to a specific receptor on liver cells and peripheral cells. It is essential for the normal catabolism of triglyceride-rich lipoprotein constituents.cite web | title = Entrez Gene: APOE apolipoprotein E| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=348| accessdate = ]

Function

APOE [cite journal |author=Singh PP, Singh M, Mastana SS |title=Genetic variation of apolipoproteins in North Indians |journal=Hum. Biol. |volume=74 |issue=5 |pages=673–82 |year=2002 |pmid=12495081 |doi=] is essential for the normal catabolism of triglyceride-rich lipoprotein constituents. APOE was initially recognized for its importance in lipoprotein metabolism and cardiovascular disease. More recently, it has been studied for its role in several biological processes not directly related to lipoprotein transport, including Alzheimer's disease (AD), immunoregulation, and cognition. Neonates with brain injuries and/or defects who also have abnormalities in the APOE gene may have an increased risk for cerebral palsy, according to researchers at the Northwestern University Feinberg School of Medicine. Defects in APOE result in familial dysbetalipoproteinemia, or type III hyperlipoproteinemia (HLP III), in which increased plasma cholesterol and triglycerides are the consequence of impaired clearance of chylomicron, VLDL and LDL remnants.

APOE is 299 amino acids long and transports lipoproteins, fat-soluble vitamins, and cholesterol into the lymph system and then into the blood. It is synthesized principally in the liver, but has also been found in other tissues such as the brain, kidneys, and spleen. In the nervous system, non-neuronal cell types, most notably astroglia and microglia, are the primary producers of APOE, while neurons preferentially express the receptors for APOE. There are seven currently identified mammalian receptors for APOE which belong to the evolutionarily conserved low density lipoprotein receptor gene family.

Gene

The APOE gene, "ApoE", is mapped to chromosome 19 in a cluster with Apolipoprotein C1 and Apolipoprotein C2. "ApoE" consists of four exons and three introns, totaling 3597 base pairs.

The gene is polymorphic [cite journal |author=Singh PP, Singh M, Mastana SS |title=APOE distribution in world populations with new data from India and the UK.|journal=Ann.Hum. Biol. |volume=33 |issue=3 |pages=279-308 |year=2006 |pmid=17092867 |doi=] with three major alleles, "ApoE2", "ApoE3", "ApoE4", which translate into three isoforms of the protein: normal - ApoE-ε3; dysfunctional - ApoE-ε2 and ApoE-ε4. These isoforms differ from each other only by single amino acid substitutions at positions 112 and 158, but have profound physiological consequences.

* E2 is associated with the genetic disorder type III hyperlipoproteinemia and with both increased and decreased risk for atherosclerosis.

* E4 has been implicated in atherosclerosis and Alzheimer's disease, impaired cognitive function, and reduced neurite outgrowth.

"ApoE" is a target gene of liver X receptor, a nuclear receptor member that play role in metabolism regulation of cholesterol, fatty acid, and glucose homeostasis.

Alzheimer's Disease

Alzheimer's Disease is characterized by plaques consisting of the peptide beta-amyloid. Apolipoprotein E enhances proteolytic break-down of this peptide, both within and between cells. Some isoforms of ApoE are not as efficient as others at catalyzing these reactions. In particular, the isoform ApoE-ε4 is not very effective, resulting in increased vulnerability to Alzheimer's in individuals with that gene variation.cite journal | author = Jiang Q, Lee CY, Mandrekar S, Wilkinson B, Cramer P, Zelcer N, Mann K, Lamb B, Willson TM, Collins JL, Richardson JC, Smith JD, Comery TA, Riddell D, Holtzman DM, Tontonoz P, Landreth GE | date = 2008-06-12 | title = ApoE promotes the proteolytic degradation of Abeta | journal = Neuron | volume = 58 | issue = 5 | pages = 681-93 | publisher = Cell Press | location = United States | issn = 1097-4199 | pmid = 18549781 | doi = 10.1016/j.neuron.2008.04.010 | url = http://download.neuron.org/pdfs/0896-6273/PIIS0896627308003280.pdf | accessdate = 2008-06-16 | laysummary = http://www.sciencedaily.com/releases/2008/06/080611135123.htm | laysource = ScienceDaily | laydate = 2008-06-13 ]

Lipidated ApoE is more effective in breaking down beta-amyloid than unlipidated ApoE. Activating liver X receptors creates more lipidated ApoE, which increases plaque removal.

The pivotal role of "ApoE" in AD was first identified through linkage analysis by Margaret Pericak-Vance while working in the Roses lab at Duke University. Linkage studies were followed by association analysis confirming the role of the ApoE4 allele. cite journal |author=Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA |title=Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families |journal=Science |volume=261 |issue=5123 |pages=921–3 |year=1993 |pmid=8346443 |doi=]

Although 40-65% of AD patients have at least one copy of the 4 allele, "ApoE4" is not a determinant of the disease - at least a third of patients with AD are "ApoE4" negative and some "ApoE4" homozygotes never develop the disease. Among ApoE4 carriers, another gene, GAB2, is thought to further influence the risk of getting AD. cite journal |author=Reiman EM, Webster JA, Myers AJ, Hardy J, Dunckley T, Zismann VL, Joshipura KD, Pearson JV, Hu-Lince D, Huentelman MJ, Craig DW, Coon KD, Liang WS, Herbert RH, Beach T, Rohrer KC, Zhao AS, Leung D, Bryden L, Marlowe L, Kaleem M, Mastroeni D, Grover A, Heward CB, Ravid R, Rogers J, Hutton ML, Melquist S, Petersen RC, Alexander GE, Caselli RJ, Kukull W, Papassotiropoulos A, Stephan DA |title=GAB2 Alleles Modify Alzheimer's Risk in APOE varepsilon4 Carriers |journal= |volume=54 |issue=5 |pages=713–720 |year=2007 |pmid=17553421 |doi=10.1016/j.neuron.2007.05.022 [http://www.neuron.org/content/article/fulltext?uid=PIIS0896627307003790&highlight=GAB2 Free full text] [http://download.neuron.org/pdfs/0896-6273/PIIS0896627307003790.pdf Free PDF] [http://www.tgen.org/research/index.cfm?pageid=1065 Genetic data in the public domain] ]

There is also evidence that the ApoE2 allele may serve a protective role in AD. cite journal |author=Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC, Rimmler JB, Locke PA, Conneally PM, Schmader KE |title=Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease |journal=Nat. Genet. |volume=7 |issue=2 |pages=180–4 |year=1994 |pmid=7920638 |doi=10.1038/ng0694-180]

Thus, the genotype most at risk for Alzheimer's disease and at earlier age is ApoE 4,4. The ApoE 3,4 genotype is at increased risk, though not to the degree that those homozygous for ApoE 4 are. The genotype ApoE 3,3 is considered at normal risk for Alzheimer's disease. The genotype ApoE 2,3 is considered at less risk for Alzheimer's disease. Interestingly, people with both a copy of the 2 allele and the 4 allele, ApoE 2,4, are at normal risk similar to the ApoE 3,3 genotype.

References

Further reading

*cite journal | author=Gunzburg MJ, Perugini MA, Howlett GJ.|title= Structural basis for the recognition and cross-linking of amyloid fibrils by human apolipoprotein E. |journal=J. Biol. Chem. |volume=282 |issue= 49 |pages= 35831-41 |year= 2007 |pmid= 17916554 |doi= 10.1074/jbc.M706425200PBB_Further_reading
citations =
*cite journal | author=Mahley RW |title=Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. |journal=Science |volume=240 |issue= 4852 |pages= 622–30 |year= 1988 |pmid= 3283935 |doi=
*cite journal | author=Strittmatter WJ, Roses AD |title=Apolipoprotein E and Alzheimer disease. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=92 |issue= 11 |pages= 4725–7 |year= 1995 |pmid= 7761390 |doi=
*cite journal | author=de Knijff P, van den Maagdenberg AM, Frants RR, Havekes LM |title=Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels. |journal=Hum. Mutat. |volume=4 |issue= 3 |pages= 178–94 |year= 1995 |pmid= 7833947 |doi= 10.1002/humu.1380040303
*cite journal | author=Roses AD, Einstein G, Gilbert J, "et al." |title=Morphological, biochemical, and genetic support for an apolipoprotein E effect on microtubular metabolism. |journal=Ann. N. Y. Acad. Sci. |volume=777 |issue= |pages= 146–57 |year= 1996 |pmid= 8624078 |doi=
*cite journal | author=Beffert U, Danik M, Krzywkowski P, "et al." |title=The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease. |journal=Brain Res. Brain Res. Rev. |volume=27 |issue= 2 |pages= 119–42 |year= 1998 |pmid= 9622609 |doi=
*cite journal | author=Mahley RW, Ji ZS |title=Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. |journal=J. Lipid Res. |volume=40 |issue= 1 |pages= 1–16 |year= 1999 |pmid= 9869645 |doi=
*cite journal | author=Mahley RW, Rall SC |title=Apolipoprotein E: far more than a lipid transport protein. |journal=Annual review of genomics and human genetics |volume=1 |issue= |pages= 507–37 |year= 2002 |pmid= 11701639 |doi= 10.1146/annurev.genom.1.1.507
*cite journal | author=Parasuraman R, Greenwood PM, Sunderland T |title=The apolipoprotein E gene, attention, and brain function. |journal=Neuropsychology |volume=16 |issue= 2 |pages= 254–74 |year= 2002 |pmid= 11949718 |doi=
*cite journal | author=Bocksch L, Stephens T, Lucas A, Singh B |title=Apolipoprotein E: possible therapeutic target for atherosclerosis. |journal=Current drug targets. Cardiovascular & haematological disorders |volume=1 |issue= 2 |pages= 93–106 |year= 2003 |pmid= 12769659 |doi=
*cite journal | author=Masterman T, Hillert J |title=The telltale scan: APOE epsilon4 in multiple sclerosis. |journal=Lancet neurology |volume=3 |issue= 6 |pages= 331 |year= 2004 |pmid= 15157846 |doi= 10.1016/S1474-4422(04)00763-X
*cite journal | author=Ashford JW |title=APOE genotype effects on Alzheimer's disease onset and epidemiology. |journal=J. Mol. Neurosci. |volume=23 |issue= 3 |pages= 157–65 |year= 2004 |pmid= 15181244 |doi=
*cite journal | author=Huang Y, Weisgraber KH, Mucke L, Mahley RW |title=Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's disease. |journal=J. Mol. Neurosci. |volume=23 |issue= 3 |pages= 189–204 |year= 2004 |pmid= 15181247 |doi=
*cite journal | author=Itzhaki RF, Dobson CB, Shipley SJ, Wozniak MA |title=The role of viruses and of APOE in dementia. |journal=Ann. N. Y. Acad. Sci. |volume=1019 |issue= |pages= 15–8 |year= 2004 |pmid= 15246985 |doi= 10.1196/annals.1297.003
*cite journal | author=Kolovou GD, Anagnostopoulou KK |title=Apolipoprotein E polymorphism, age and coronary heart disease. |journal=Ageing Res. Rev. |volume=6 |issue= 2 |pages= 94–108 |year= 2007 |pmid= 17224309 |doi= 10.1016/j.arr.2006.11.001
*cite journal | author=Lambert JC, Amouyel P |title=Genetic heterogeneity of Alzheimer's disease: complexity and advances. |journal=Psychoneuroendocrinology |volume=32 Suppl 1 |issue= |pages= S62–70 |year= 2007 |pmid= 17659844 |doi= 10.1016/j.psyneuen.2007.05.015
*cite journal | author=Raber J |title=Role of apolipoprotein E in anxiety. |journal=Neural Plast. |volume= |issue= |pages= 91236 |year= 2007 |pmid= 17710250 |doi= 10.1155/2007/91236
*cite journal | author=Ye J |title=Reliance of host cholesterol metabolic pathways for the life cycle of hepatitis C virus. |journal=PLoS Pathog. |volume=3 |issue= 8 |pages= e108 |year= 2007 |pmid= 17784784 |doi= 10.1371/journal.ppat.0030108
*cite journal | author=Bennet AM, Di Angelantonio E, Ye Z, "et al." |title=Association of apolipoprotein E genotypes with lipid levels and coronary risk. |journal=JAMA |volume=298 |issue= 11 |pages= 1300–11 |year= 2007 |pmid= 17878422 |doi= 10.1001/jama.298.11.1300
*cite journal | author=Utermann G, Pruin N, Steinmetz A |title=Polymorphism of apolipoprotein E. III. Effect of a single polymorphic gene locus on plasma lipid levels in man. |journal=Clin. Genet. |volume=15 |issue= 1 |pages= 63–72 |year= 1979 |pmid= 759055 |doi=
*cite journal | author=Moriyama K, Sasaki J, Matsunaga A, "et al." |title=Apolipoprotein E1 Lys-146----Glu with type III hyperlipoproteinemia. |journal=Biochim. Biophys. Acta |volume=1128 |issue= 1 |pages= 58–64 |year= 1992 |pmid= 1356443 |doi=

External links

*

PBB_Controls
update_page = yes
require_manual_inspection = no
update_protein_box = yes
update_summary = no
update_citations = yes


Wikimedia Foundation. 2010.

Игры ⚽ Нужен реферат?

Look at other dictionaries:

  • Apolipoprotein D — Apolipoprotein D, also known as APOD, is a human gene.cite web | title = Entrez Gene: APOD apolipoprotein D| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene Cmd=ShowDetailView TermToSearch=347| accessdate = ] PBB Summary section title =… …   Wikipedia

  • Apolipoprotein C3 — Apolipoprotein C III is a very low density lipoprotein (VLDL) protein. APOC3 inhibits lipoprotein lipase and hepatic lipase; it is thought to delay catabolism of triglyceride rich particles. The APOA1, APOC3 and APOA4 genes are closely linked in… …   Wikipedia

  • Apolipoprotein A1 — Apolipoprotein A I, also known as APOA1, is a human gene.The protein encoded by this gene is an apolipoprotein. It is the major protein component of high density lipoprotein (HDL) in plasma. The protein promotes cholesterol efflux from tissues to …   Wikipedia

  • Apolipoprotein B — (APOB) is the primary apolipoprotein of low density lipoproteins (LDL or bad cholesterol ), which is responsible for carrying cholesterol to tissues. While it is unclear exactly what functional role APOB plays in LDL, it is the primary… …   Wikipedia

  • Apolipoprotein E — Bändermodell der Aminosäuren 1 191 des Apolipoprotein E4 nach PDB  …   Deutsch Wikipedia

  • Apolipoprotein A1 — Zwei ApoA1 Moleküle (lila Bänder) im Komplex mit Cholesterin (orange Kalotten) und Phospholip …   Deutsch Wikipedia

  • Apolipoprotein H — (Apo H), previously known as (β2 glycoprotein I, beta 2 glycoprotein I), is a multifunctional apolipoprotein. One of its functions is to bind cardiolipin. When bound the structure of cardiolipin and Apo H both undergo large changes in… …   Wikipedia

  • Apolipoprotein — Als Apolipoproteine (Apo von griechisch άπό: Ab , Weg ) bezeichnet man den Proteinanteil der Lipoproteine (u. a. Chylomikronen, VLDL, LDL, IDL, HDL), der die wasserunlöslichen Lipide im Blut transportiert. Die Apolipoproteine bilden zusammen mit… …   Deutsch Wikipedia

  • Apolipoprotein — Apolipoproteins are proteins that bind to fats (lipids). They form lipoproteins, which transport dietary fats through the bloodstream. Dietary fats are digested in the intestine and carried to the liver. Fats are also synthesized in the liver… …   Wikipedia

  • Apolipoprotein C2 — protein Name=apolipoprotein C II caption= width= HGNCid=609 Symbol=APOC2 AltSymbols= EntrezGene=344 OMIM=608083 RefSeq=NM 000483 UniProt=P02655 PDB= ECnumber= Chromosome=19 Arm=q Band=13.2 LocusSupplementaryData=Apolipoprotein C2 is an… …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”